Abstract Purpose of Review Few treatments are available for patients with mood disorders or
post-traumatic stress disorder (PTSD) who have already failed multiple interventions. After …

In clinical research settings around the world, renewed investigations are taking place on
the use of psychedelic substances for treating illnesses such as addiction, depression …

Research on psychedelics has seen a recent revival, with many clinical trials focused on
their therapeutic potential to treat a range of mental health conditions. The purpose of this …

Psychedelic substances are under investigation in several drug development programs.
Controlled clinical trials are providing evidence for safe and effective use of psychedelic …

Despite the popular support for psychedelics as aids for depression, academics and the
public frequently overestimate the efficacy of available medications and psychotherapies …

Psychedelics (ie, ketamine, methylenedioxymethamphetamine, psilocybin) have been
effectively used globally for centuries to treat mental health and addiction issues. However …

Though there was initial interest in the use of psychedelic drugs for psychiatric treatment,
bad outcomes and subsequent passage of the Substance Act of 1970, which placed …

The re-emergence of therapeutic uses for mind-altering, psychedelic drugs has brought the
field of mental health to a new frontier in research, practice, and policymaking. In the past …

International research is increasingly demonstrating that psychedelic‐assisted
psychotherapy can enhance psychotherapeutic outcomes and be effective for some …

Psychedelic plants and fungi have been used in indigenous medicinal traditions for
millennia. Modern psychedelic research began when Albert Hofmann first synthesized …